Jia‐Yi Deng

428 total citations
22 papers, 305 citations indexed

About

Jia‐Yi Deng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Jia‐Yi Deng has authored 22 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Jia‐Yi Deng's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (4 papers). Jia‐Yi Deng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (4 papers). Jia‐Yi Deng collaborates with scholars based in China, Japan and United States. Jia‐Yi Deng's co-authors include Toshiaki Nakano, King‐Wah Chiu, Hock‐Liew Eng, Chia-Yun Lai, Chih‐Chi Wang, Bruno Jawan, Yu‐Fan Cheng, Shigeru Goto, Li‐Wen Hsu and Kuang‐Den Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Food Chemistry.

In The Last Decade

Jia‐Yi Deng

18 papers receiving 301 citations

Peers

Countries citing papers authored by Jia‐Yi Deng

Since Specialization

Citations

This map shows the geographic impact of Jia‐Yi Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Yi Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Yi Deng more than expected).

Fields of papers citing papers by Jia‐Yi Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Yi Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Yi Deng. The network helps show where Jia‐Yi Deng may publish in the future.

Co-authorship network of co-authors of Jia‐Yi Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Yi Deng. A scholar is included among the top collaborators of Jia‐Yi Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Yi Deng. Jia‐Yi Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Operational Modal Analysis of a Monopile Offshore Wind Turbine via Bayesian Spectral Decomposition 2025 ·Journal of Marine Science and Engineering ·Mumin Rao, Xugang Hua, Chi Yu, Zhouquan Feng, Jia‐Yi Deng, Ziyuan Yang, (unknown), (unknown), Zhichao Wu	0
2	Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study 2025 ·Journal of Inflammation Research ·Yibo He, (unknown), Xinlei Miao, (unknown), Jia‐Yi Deng, (unknown), Meng Li, Ming Ye, Song Leng	1
3	Flavoromics analysis and sensory evaluation of wines produced from nine red grape cultivars in Manas region, Xinjiang, China: Implications for terroir adaptation 2025 ·Food Chemistry ·Ning Shi, Yifan Zhao, Hao-Cheng Lu, (unknown), Mingyu Li, Jia‐Yi Deng, Jialiu Wei, (unknown), (unknown), Shu-De Li, Fei He, Keji Yu, Chang‐Qing Duan, Jun Wang	3
4	Afternoon shading delays ripening and modifies grape flavonoids and wine composition under natural heat stress in semi-arid regions 2025 ·Food Chemistry X ·(unknown), Hao-Cheng Lu, Ning Shi, Mingyu Li, Jialiu Wei, Jia‐Yi Deng, (unknown), Shu-De Li, Fei He, Chang‐Qing Duan, Keji Yu, Jun Wang	0
5	Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer 2025 ·Cancer Immunology Immunotherapy ·Jia‐Yi Deng, Ming Gao, Xue Fan, (unknown), (unknown), Mingyi Yang, Xiaorong Yang, Zhihong Chen, Chong‐Rui Xu, (unknown)	0
6	Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study 2024 ·BMC Cancer ·Jia‐Yi Deng, (unknown), Xiaorong Yang, Zhihong Chen, Chong‐Rui Xu, (unknown)	2
7	Redox ^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma 2024 ·OncoImmunology ·Xue‐Wu Wei, (unknown), (unknown), Xue Fan, Chong‐Rui Xu, Zhihong Chen, Fen Wang, Xiaorong Yang, Jia‐Yi Deng, (unknown), (unknown), (unknown), (unknown), (unknown), Wen‐Zhao Zhong, Jin‐Ji Yang, Xu‐Chao Zhang, (unknown), Yi‐Long Wu, Qing Zhou	11
8	Fiber morphological characteristics of bamboo Ferrocalamus strictus culms from different geographical distribution regions 2024 ·Journal of Wood Science ·(unknown), (unknown), (unknown), (unknown), Z.D. Zhou, Hui Zhan, (unknown), Jia‐Yi Deng, Changming Wang	0
9	Drug development and evidence for lung cancer targeted therapy in Eastern Asia 2024 ·The Lancet Regional Health - Western Pacific ·Si‐Yang Maggie Liu, (unknown), Jia‐Yi Deng, Sen Zhong, Myung‐Ju Ahn, Hidehito Horinouchi, Yangqiu Li, Yi‐Long Wu	3
10	Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study 2024 ·Lipids in Health and Disease ·(unknown), Xinlei Miao, Xiaoling Xie, (unknown), Jia‐Yi Deng, (unknown), (unknown), Song Leng	1
11	MXenes as catalysts for lightweight hydrogen storage materials: A review 2024 ·SHILAP Revista de lepidopterología ·Jia‐Yi Deng, (unknown), Hua Ning, (unknown), Xiantun Huang, Hui Luo, Liang Zhang, Guangxu Li, Cunke Huang, (unknown), Wenzheng Zhou, Jin Guo, Xinhua Wang, Haizhen Liu	17
12	Hybrid of bulk NbC and layered Nb4C3 MXene for tailoring the hydrogen storage kinetics and reversibility of Li–Mg–B–H composite: An experimental and theoretical study 2024 ·Journal of Material Science and Technology ·Haizhen Liu, Liwen Lu, Hui Luo, Jia‐Yi Deng, Guangxu Li, Hua Ning, Yi Fan, Cunke Huang, Zhiqiang Lan, Wenzheng Zhou, Jin Guo, Xinhua Wang	18
13	Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Jia‐Yi Deng, (unknown), Lingling Yang, Zhihong Chen, (unknown), Xiaorong Yang, Hong‐Hong Yan, Xue‐Wu Wei, (unknown), Jian Su, Wen‐Zhao Zhong, Chong‐Rui Xu, Yi‐Long Wu, Qing Zhou	23
14	PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial 2023 ·Science Bulletin ·Si‐Yang Maggie Liu, Jie Huang, Jia‐Yi Deng, Chong‐Rui Xu, Hong‐Hong Yan, (unknown), Yang-Si Li, (unknown), E‐E Ke, Ming-Ying Zheng, Zhen Wang, Jiaxin Lin, Bin Gan, Xu‐Chao Zhang, Hua‐Jun Chen, Bin-Chao Wang, Hai‐Yan Tu, Jin‐Ji Yang, Wen‐Zhao Zhong, (unknown), (unknown), Qing Zhou, Yi‐Long Wu	18
15	A randomised sham-controlled study evaluating rTMS analgesic efficacy for postherpetic neuralgia 2023 ·Frontiers in Neuroscience ·(unknown), (unknown), Jia‐Yi Deng, Ye Yang, Manli Huang, Xianwei Che, (unknown)	11
16	Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer 2023 ·Molecular Carcinogenesis ·Xiaorong Yang, (unknown), (unknown), Zhihong Chen, Xu‐Chao Zhang, (unknown), Lingling Yang, Jiani C. Yin, Jia‐Yi Deng, Mingyi Yang, (unknown), Yi‐Long Wu, Qing Zhou	6
17	Characteristics of and Treatment Strategies for Advanced EGFR-Mutant NSCLC With Concomitant BRAF Variations 2022 ·JTO Clinical and Research Reports ·Xue‐Wu Wei, Jia‐Yi Deng, Chong‐Rui Xu, Zhihong Chen, Dongqin Zhu, Qian Wu, Xu‐Chao Zhang, Yi‐Long Wu, Qing Zhou	4
18	Sintilimab versus pembrolizumab in monotherapy or combination with chemotherapy as first-line therapy for advanced non–small cell lung cancer: Results from phase 2, randomized clinical trial (CTONG1901). 2022 ·Journal of Clinical Oncology ·Si‐Yang Maggie Liu, Qing Zhou, Hong‐Hong Yan, (unknown), (unknown), Jia‐Yi Deng, Hai‐Yan Tu, Xu‐Chao Zhang, Jian Su, Jin‐Ji Yang, Yi‐Long Wu	11
19	Clinical outcomes of non–small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments 2021 ·European Journal of Cancer ·Mei-Mei Zheng, Hai‐Yan Tu, Jin‐Ji Yang, Xu‐Chao Zhang, Qing Zhou, Chong‐Rui Xu, Ben‐Yuan Jiang, Xue‐Ning Yang, Xiaorong Yang, Jia‐Yi Deng, (unknown), Bing-Fei Xu, Xiu‐Mei Chen, Yang-Si Li, Yi‐Long Wu	19
20	Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats 2010 ·Journal of Hepatology ·Toshiaki Nakano, Yu‐Fan Cheng, Chia-Yun Lai, Li‐Wen Hsu, (unknown), Jia‐Yi Deng, (unknown), Hiroyuki Honda, Kuang‐Den Chen, Chih‐Chi Wang, King‐Wah Chiu, Bruno Jawan, Hock‐Liew Eng, Shigeru Goto, Chao‐Long Chen	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact